Featured
-
-
Article
| Open AccessA phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults
- Satoshi Iwata
- , Andrew J. Pollard
- & Takuhiro Sonoyama
-
Article
| Open AccessSARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
- Chapin S. Korosec
- , David W. Dick
- & James Watmough
-
Article
| Open AccessAdaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study
- Gabrielle N. Gaultier
- , Brynn McMillan
- & Manish Sadarangani
-
Article
| Open AccessSeroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco
- Sayeh Ezzikouri
- , Raji Tajudeen
- & Abderrahmane Maaroufi
-
Article
| Open AccessComprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults
- Laise Rodrigues Reis
- , Ismael Artur Costa-Rocha
- & Olindo Assis Martins-Filho
-
Article
| Open AccessImmune protection of three serine protease inhibitors vaccine in mice against Rhipicephalus sanguineus
- Xiaoya Zhao
- , Jianguo Zhao
- & Qian Han
-
Article
| Open AccessAn effective COVID-19 vaccine hesitancy intervention focused on the relative risks of vaccination and infection
- Cameron O’Neill Byerley
- , Dru Horne
- & Sukjin You
-
Article
| Open AccessImmunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus
- Truc Ly Nguyen
- & Heebal Kim
-
Article
| Open AccessImpact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
- Lucy Rutten
- , Maarten Swart
- & Johannes P. M. Langedijk
-
Article
| Open AccessDesigning a T-cell epitope-based vaccine using in silico approaches against the Sal k 1 allergen of Salsola kali plant
- Mohammad Hossein Shams
- , Seyyed Mohsen Sohrabi
- & Mohammad-Ali Assarehzadegan
-
Article
| Open AccessExploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study
- Samar A. Amer
- , Ali Al-Zahrani
- & Hebatallah M. Fawzy
-
Article
| Open AccessImmunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
- Chimuka Handabile
- , Marumi Ohno
- & Hiroshi Kida
-
Article
| Open AccessEfficacy evaluation of a bivalent subunit vaccine against classical swine fever virus and porcine circovirus type 2
- Yu-San Chen
- , Chang-Ye Lee
- & Charles Chen
-
Article
| Open AccessUltra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria
- Felicia N. Watson
- , Melanie J. Shears
- & Sean C. Murphy
-
Article
| Open AccessProfiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites
- Mary Lopez-Perez
- , Aarti Jain
- & Myriam Arévalo-Herrera
-
Article
| Open AccessAssociation of vaccine status, reinfections, and risk factors with Long COVID syndrome
- Maria Elena Romero-Ibarguengoitia
- , Juan Francisco Rodríguez-Torres
- & Maria Rescigno
-
Article
| Open AccessAnalysis of related factors of plasma antibody levels in patients with severe and critical COVID-19
- Yudi Xie
- , Yang Xia
- & Zhong Liu
-
Article
| Open AccessPhase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study
- Thanyawee Puthanakit
- , Eakachai Prompetchara
- & Ponsuk Visudhipan Grandin
-
Article
| Open AccessLongitudinal analysis of influenza vaccination implicates regulation of RIG-I signaling by DNA methylation
- Hongxiang Fu
- , Harry Pickering
- & Matteo Pellegrini
-
Article
| Open AccessMultivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses
- Naoko Uno
- & Ted M. Ross
-
Article
| Open AccessNaturally acquired antibodies against Plasmodium vivax pre-erythrocytic stage vaccine antigens inhibit sporozoite invasion of human hepatocytes in vitro
- Francis Babila Ntumngia
- , Surendra Kumar Kolli
- & John H. Adams
-
Article
| Open AccessImpact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
- Laura Sánchez-de Prada
- , Ana María Martínez-García
- & José M. Eiros
-
Article
| Open AccessOmicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model
- Asghar Abdoli
- , Hamidreza Jamshidi
- & Hasan Jalili
-
Article
| Open AccessImmunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis
- Jenna M. Benoit
- , Jessica A. Breznik
- & Dawn M. E. Bowdish
-
Article
| Open AccessA potent subset of Mycobacterium tuberculosis glycoproteins as relevant candidates for vaccine and therapeutic target
- Shamsi Yari
- , Parviz Afrough
- & Alireza Hadizadeh Tasbiti
-
Article
| Open AccessRotavirus genotype diversity in Tanzania during Rotavirus vaccine implementation between 2013 and 2018
- Fausta Michael
- , Mariam M. Mirambo
- & Stephen E. Mshana
-
Article
| Open AccessA real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area
- Min Huang
- , Lu Jia
- & Libo Zhang
-
Article
| Open AccessEffectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
- Saina Beitari
- , Gerard Agbayani
- & Anh Tran
-
Article
| Open AccessForecasting local hospital bed demand for COVID-19 using on-request simulations
- Raisa Kociurzynski
- , Angelo D’Ambrosio
- & Tjibbe Donker
-
Article
| Open AccessSafety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models
- Felipe Lelis
- , Laura A. Byk
- & Antu K. Dey
-
Article
| Open AccessEvaluating the stability of host-reference gene expression and simultaneously quantifying parasite burden and host immune responses in murine malaria
- Daniel J. Browne
- , Ashton M. Kelly
- & Denise L. Doolan
-
Article
| Open AccessPlant-based production of a protective vaccine antigen against the bovine parasitic nematode Ostertagia ostertagi
- Laurens Zwanenburg
- , Jimmy Borloo
- & Peter Geldhof
-
Article
| Open AccessHumoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine
- Niloofar Najafi
- , Hoorieh Soleimanjahi
- & Zeynab Nasiri
-
Article
| Open AccessExploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
- Manette Tanelus
- , Krisangel López
- & Albert J. Auguste
-
Article
| Open AccessPsychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France
- Damien Oudin Doglioni
- , Amandine Gagneux-Brunon
- & Judith E. Mueller
-
Article
| Open AccessImpact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine
- Masahiko Mori
- , Aiko Yokoyama
- & Tadayoshi Moriyama
-
Article
| Open AccessA novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses
- Katarzyna Kuczkowska
- , Louise Bjerkan
- & Gunnstein Norheim
-
Article
| Open AccessA two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines
- Arnone Nithichanon
- , Ludthawun Kamuthachad
- & Supranee Phanthanawiboon
-
Article
| Open AccessMolecular imaging of bacterial outer membrane vesicles based on bacterial surface display
- Dávid Szöllősi
- , Polett Hajdrik
- & Krisztián Szigeti
-
Article
| Open AccessPhosphatidylinositolmannoside vaccination induces lipid-specific Th1-responses and partially protects guinea pigs from Mycobacterium tuberculosis challenge
- Emmelie Eckhardt
- , Jan Schinköthe
- & Max Bastian
-
Article
| Open AccessAssessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein
- Gerco den Hartog
- , Stijn P. Andeweg
- & Robert S. van Binnendijk
-
Article
| Open AccessFactors associated with COVID-19 vaccination among pregnant women in Rio De Janeiro City, Brazil
- Moara Alves Santa Bárbara Borges
- , Pilar Tavares Veras Florentino
- & Enny S. Paixão
-
Article
| Open AccessBNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
- Chee Fu Yung
- , Nina Le Bert
- & Linfa Wang
-
Article
| Open AccessNeutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron
- Masayuki Amano
- , Sachiko Otsu
- & Hiroaki Mitsuya
-
Article
| Open AccessTherapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
- Jakub Kopycinski
- , Hongbing Yang
- & Lucy Dorrell
-
Article
| Open AccessA computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages
- Michael A. Carlock
- & Ted M. Ross
-
Article
| Open AccessEfficacy of a synthetic peptide Chlamydia pecorum major outer membrane protein vaccine in a wild koala (Phascolarctos cinereus) population
- Sarah J. Simpson
- , Damien P. Higgins
- & Mark B. Krockenberger
-
Article
| Open AccessSide effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study
- Alexander Winkelmann
- , Christoph Metze
- & Micha Loebermann
-
Article
| Open AccessAntibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine
- Alexander Rouvinski
- , Ahuva Friedman
- & Herve Bercovier